Price target
893.230.000.00%
The 6 analysts offering 1 year price forecasts for RPRX/N have a max estimate of — and a min estimate of —.
Analyst rating
Based on 10 analysts giving stock ratings to RPRX/N in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
RPRX/N EPS for the last quarter is 18.08 MXN despite the estimation of 18.28 MXN. In the next quarter EPS is expected to reach 21.12 MXN. Track more of ROYALTY PHARMA PLC financials and stay on top of what is up with the company.
In the next quarter ROYALTY PHARMA PLC revenue is expected to reach 12.16 B MXN. Check out ROYALTY PHARMA PLC revenue and earnings and make informed decisions.
According to analysts, RPRX/N price target is 893.23 MXN with a max estimate of 1,031.43 MXN and a min estimate of 788.74 MXN. Check if this forecast comes true in a year, meanwhile watch ROYALTY PHARMA PLC stock price chart and keep track of the current situation with RPRX/N news and stock market news.
We've gathered opinions of 10 analysts rating RPRX/N stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.